Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 1
2020 5
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic inhibitors and their role in cancer therapy.
Abdelaziz N, Therachiyil L, Sadida HQ, Ali AM, Khan OS, Singh M, Khan AQ, Akil ASA, Bhat AA, Uddin S. Abdelaziz N, et al. Among authors: therachiyil l. Int Rev Cell Mol Biol. 2023;380:211-251. doi: 10.1016/bs.ircmb.2023.04.005. Epub 2023 Aug 1. Int Rev Cell Mol Biol. 2023. PMID: 37657859
Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma.
Adeeb M, Therachiyil L, Moton S, Buddenkotte J, Alam MA, Uddin S, Steinhoff M, Ahmad A. Adeeb M, et al. Among authors: therachiyil l. Int Rev Cell Mol Biol. 2023;380:149-171. doi: 10.1016/bs.ircmb.2023.04.004. Epub 2023 Jul 21. Int Rev Cell Mol Biol. 2023. PMID: 37657857 Review.
The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).
Inchakalody VP, Hydrose SP, Krishnankutty R, Merhi M, Therachiyil L, Sasidharan Nair V, Elashi AA, Khan AQ, Taleb S, Raza A, Yoosuf ZSKM, Fernandes Q, Al-Zaidan L, Mestiri S, Taib N, Bedhiafi T, Moustafa D, Assami L, Maalej KM, Elkord E, Uddin S, Al Homsi U, Dermime S. Inchakalody VP, et al. Among authors: therachiyil l. Eur J Pharmacol. 2023 Apr 15;945:175612. doi: 10.1016/j.ejphar.2023.175612. Epub 2023 Feb 22. Eur J Pharmacol. 2023. PMID: 36822455 Free article.
Role of RAS signaling in ovarian cancer.
Therachiyil L, Anand A, Azmi A, Bhat A, Korashy HM, Uddin S. Therachiyil L, et al. F1000Res. 2022 Nov 4;11:1253. doi: 10.12688/f1000research.126337.1. eCollection 2022. F1000Res. 2022. PMID: 36451660 Free PMC article. Review.
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.
Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, Al-Mannai S, Therachiyil L, Mir R, Elfaki I, Mir MM, Jamal F, Masoodi T, Uddin S, Singh M, Haris M, Macha M, Bhat AA. Hashem S, et al. Among authors: therachiyil l. Biomed Pharmacother. 2022 Jun;150:113054. doi: 10.1016/j.biopha.2022.113054. Epub 2022 Apr 30. Biomed Pharmacother. 2022. PMID: 35658225 Free article. Review.
18 results